Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
Mission Bio's investors include Alumni Ventures, Mayfield Fund, Fusion Fund, National Science Foundation, Cota Capital.
Mission Bio is headquartered in San Francisco, United States.
Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.
Mission Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mission Bio — Funding & Investors." VCBacked, August 5, 2025, https://www.vcbacked.co/company/mission-bio. Accessed July 23, 2026.
VCBacked. (2025). Mission Bio — Funding & Investors. Retrieved July 23, 2026, from https://www.vcbacked.co/company/mission-bio
{{cite web |title=Mission Bio — Funding & Investors |url=https://www.vcbacked.co/company/mission-bio |website=VCBacked |access-date=July 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated